Tokyo, Aug. 4 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058684) titled 'Study on eosinophil surface antigens in non-asthmatic chronic obstructive pulmonary disease (COPD)' on Aug. 4.
Study Type:
Observational
Primary Sponsor:
Institute - Kurume University
Condition:
Condition - non-asthmatic chronic obstructive pulmonary disease (COPD)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To verify whether the ratio of inflammatory eosinophils/non-activated (resident) eosinophils classified by eosinophil surface antigens is related to the clinical pathology and treatment of pure COPD.
Basic objectives2 - Bio-availability
Eligibility:
Age-lower limit - 40
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Chronic obstructive pulmonary disease (COPD)
Key exclusion criteria - asthma
Target Size - 100
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 07 Month 23 Day
Date of IRB - 2025 Year 07 Month 23 Day
Anticipated trial start date - 2025 Year 08 Month 04 Day
Last follow-up date - 2026 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067102
Disclaimer: Curated by HT Syndication.
